Letter: the Relationship Between Diet, Mood and Mucosal Healing in Coeliac Disease Remains to Be Verified

Jian Zeng,Hua-Tian Gan

DOI: https://doi.org/10.1111/apt.15041

IF: 9.524

2019-01-01

Alimentary Pharmacology & Therapeutics

Abstract:Linked Content This article is linked to Ludvigsson et al and Ludvigsson and Emilsson papers. To view these articles visit https://doi.org/10.1111/apt.14991 and https://doi.org/10.1111/apt.15055 .

What problem does this paper attempt to address?

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy

Laura Kivelä,Katri Lindfors,Knut E A Lundin,Ketil Størdal

DOI: https://doi.org/10.1111/apt.18234

2024-09-05

Abstract:Background: In coeliac disease and environmental enteropathy, dietary gluten and enteric infections cause reversible inflammation and morphological changes to the small intestinal mucosa that can be detected in biopsy samples obtained by endoscopy. However, there is a clear need for non-invasive biomarkers. Constant shedding of mucosal material into the bowel lumen and faeces, together with easy availability of stool, makes it an interesting sample matrix. Aims: To conduct a systematic literature search and summarize the existing evidence for host mucosa-derived faecal biomarkers in evaluating small intestinal damage. Methods: We searched for studies on PubMed (MEDLINE) until 1 March 2024. Results: We identified 494 studies and included 35 original case-control and cohort studies. These assessed host mucosal transcripts and 14 other markers aiming specifically to reflect inflammation and cell-mediated, innate and gluten-induced immune responses. In coeliac disease, faecal calprotectin and anti-gliadin, tissue transglutaminase, endomysium and deamidated gliadin peptide antibodies were the most studied but with inconsistent results. Single studies reported positive findings about microRNA transcripts, β-defensin-2, lipocalin-2, zonulin-related proteins and angiotensin-converting enzyme. In environmental enteropathy, a non-significant association was reported between calprotectin and urine lactulose/mannitol ratio; there were conflicting results for neopterin, myeloperoxidase and host transcripts. Single studies reported a positive association for lactoferrin, and a negative association for regenerating islet-derived protein 1. Studies comparing faecal markers against small intestinal biopsy findings were not identified in environmental enteropathy. Conclusions: Further studies are needed to determine reliable faecal markers as a proxy for small intestinal mucosal damage.
Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications

Anthony K. Akobeng,Parul Singh,Manoj Kumar,Souhaila Al Khodor

DOI: https://doi.org/10.1007/s00394-020-02324-y

IF: 4.8646

2020-07-10

European Journal of Nutrition

Abstract:Abstract Purpose Although genetic predisposition and exposure to dietary gluten are considered necessary triggers for the development of coeliac disease, alterations in the gut microbial composition may also contribute towards the pathogenesis of coeliac disease. This review aims to provide an overview of the available data on the potential mechanisms through which the gut microbiota plays a role in the causation of coeliac disease and to discuss the potential therapeutic strategies that could diminish the consequences of microbial dysbiosis. Method A search of the literature was performed using the PubMed, Embase, and JSTOR databases; relevant articles were included. Results Recent studies in patients with coeliac disease have reported an increase in the relative amounts of gram negative bacterial genera such as Bacteroides , Prevotella , and Escherichia , and reduced amounts of protective anti-inflammatory bacteria such as Bifidobacteria and Lactobacilli . Dysbiotic microbiota may lead to a dysregulated immune response that may contribute to the pathogenesis of coeliac disease. In infancy, antibiotic use and certain infant feeding practices may lead to alterations in the developing gut microbiota to influence the immune maturation process and predispose to coeliac disease. Conclusion The induction of the intestinal immune system and gluten intolerance may be influenced by the relative abundance of certain microbiota. Factors such as infant feeding practices, diet, antibiotics, and infections, may be involved in the development of coeliac disease due to their influence on gut microbial composition. The efficacy of potential modulators of the gut microbiota such as probiotics, prebiotics, and fecal microbial transplant as adjunctive treatments to gluten-free diet in coeliac disease is unproven and requires further investigation.

nutrition & dietetics
Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review

Wen Zeng,Dong He,Yifan Xing,Junyu Liu,Nan Su,Chong Zhang,Yi Wang,Xinhui Xing

DOI: https://doi.org/10.1016/j.fshw.2021.02.016

IF: 7

2021-03-01

Food Science and Human Wellness

Abstract:Ulcerative colitis (UC) is a chronic systematic inflammation disorder with increasing incidence, unknown pathogenesis, limited drug treatment, and abundant medical expenses. Dietary intake, as a daily indispensable environment factor, is closely related to UC pathogenesis and prevention. The underlying interactions between dietary intake and UC progression are implicated with the modulation of gut microbiome as well as microbial metabolites, suggesting the complex and systematic characteristics of UC. However, the triangular relationships with dietary intake, gut microbiota homeostasis, and UC have not been well summarized so far. Here we review the recent studies of dietary intake on the regulation of gut microbiome homeostasis as well as modulation of UC progression. These findings suggest that varieties in dietary patterns result in the production of diverse microbial fermentation metabolites, which contribute to gut microbiome homeostasis through multiple manipulations including immune modulation, inflammation restriction as well as epithelial barrier maintenance, thus finally determine the fate of UC progression and give implications for functional food development for prevention and treatment of UC patients.

food science & technology,nutrition & dietetics
Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota

Alessandro Annunziato,Mirco Vacca,Fernanda Cristofori,Vanessa Nadia Dargenio,Giuseppe Celano,Ruggiero Francavilla,Maria De Angelis

DOI: https://doi.org/10.3390/nu16111649

IF: 5.9

2024-05-28

Nutrients

Abstract:There is increasing evidence indicating that changes in both the composition and functionality of the intestinal microbiome are closely associated with the development of several chronic inflammatory diseases, with celiac disease (CeD) being particularly noteworthy. Thanks to the advent of culture-independent methodologies, the ability to identify and quantify the diverse microbial communities residing within the human body has been significantly improved. However, in the context of CeD, a notable challenge lies in characterizing the specific microbiota present on the mucosal surfaces of the intestine, rather than relying solely on fecal samples, which may not fully represent the relevant microbial populations. Currently, our comprehension of the composition and functional importance of mucosa-associated microbiota (MAM) in CeD remains an ongoing field of research because the limited number of available studies have reported few and sometimes contradictory results. MAM plays a crucial role in the development and progression of CeD, potentially acting as both a trigger and modulator of the immune response within the intestinal mucosa, given its proximity to the epithelial cells and direct interaction. According to this background, this review aims to consolidate the existing literature specifically focused on MAM in CeD. By elucidating the complex interplay between the host immune system and the gut microbiota, we aim to pave the way for new interventions based on novel therapeutic targets and diagnostic biomarkers for MAM in CeD.

nutrition & dietetics
Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment

Roberta Elisa Rossi,Giulia Dispinzieri,Alessandra Elvevi,Sara Massironi

DOI: https://doi.org/10.3390/cells12060823

IF: 6

2023-03-08

Cells

Abstract:Celiac disease (CD) is a common systemic disorder that results from an abnormal response of human immunity to gluten intake, affecting the small intestine. In individuals who carry a genetic susceptibility, CD is triggered by environmental factors, including viral infections and dysbiosis of the gut microbiota. The gut microbiome is essential in controlling the immune system, and recent findings indicate that changes in the gut microbiome may contribute to various chronic immune disorders, such as CD through mechanisms that still require further exploration. Some bacteria exhibit epitopes that mimic gliadin and may enhance an immune response in the host. Other bacteria, including Pseudomonas aeruginosa, may work in conjunction with gluten to trigger and escalate intestinal inflammation. The microbiota may also directly influence antigen development through the production of immunogenic or tolerogenic gluten peptides or directly influence intestinal permeability through the release of zonulin. Finally, the gut microbiome can impact intestinal inflammation by generating proinflammatory or anti-inflammatory cytokines and metabolites. It is crucial to consider the impact of genetic factors (specifically, HLA-DQ haplotypes), perinatal elements such as birth mode, type of infant feeding, and antibiotic and infection exposure on the composition of the early intestinal microbiome. According to the available studies, the gut microbiome alterations associated with CD tend to exhibit a decreased presence of beneficial bacteria, including some anti-inflammatory Bifidobacterium species. However, some controversy remains as some reports have found no significant differences between the gut microbiomes of individuals with and without CD. A better understanding of the gut microbiome's role in the development of CD would greatly benefit both prevention and treatment efforts, especially in complicated or treatment-resistant cases. Here, we have attempted to summarize the available evidence on the relationship between the gut microbiota and CD, with a particular focus on potential therapeutic targets.

cell biology
Review article: Mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn's disease

Sarah L Melton,Kirstin M Taylor,Peter R Gibson,Emma P Halmos

DOI: https://doi.org/10.1111/apt.17451

Abstract:Background: Exclusive enteral nutrition (EEN) induces remission and mucosal healing in patients with Crohn's disease, but the mechanism of action remains unknown. Aim: To outline current understanding of the mechanisms of action of EEN. Methods: From a comprehensive literature search, published data were critically examined in a narrative review. Results: Multiple potential mechanisms of action have been identified. EEN optimises nutritional status. Differences in gut microbiota in terms of overall diversity and taxonomic community structure are observed between responders and non-responders to EEN. Therapy with EEN alters microbial metabolites (including faecal short-chain fatty acids, amino acids, branched-chain amino acids and sulphide) and faecal pH. Epithelial effects and restoration of barrier function, as well as changes in mucosal cytokine profiles and T-cell subsets are observed in responders to EEN. The impact of inclusion or exclusion of specific dietary components may be of importance, but putative detrimental components are found in many formulas. A major challenge in interpreting these findings is that they often contradict or change in opposite directions to what is considered 'beneficial'. It is difficult to differentiate between the observations following EEN being driven by EEN per se and those associated with resolving inflammation. Conclusions: The mechanisms of action of EEN are likely to involve a complex interplay between host mucosal immune response and luminal environment, but the identity of key factors remains poorly understood. A better definition of pathogenic factors may aid in developing more targeted dietary treatment and provide insights into the pathogenesis of Crohn's disease.
Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment

Elena F Verdu,Detlef Schuppan

DOI: https://doi.org/10.1053/j.gastro.2021.08.016

IF: 29.4

Gastroenterology

Abstract:Celiac disease (CeD) is a frequent immune-mediated disease that affects not only the small intestine but also many extraintestinal sites. The role of gluten proteins as dietary triggers, HLA-DQ2 or -DQ8 as major necessary genetic predisposition, and tissue transglutaminase (TG2) as mechanistically involved autoantigen, are unique features of CeD. Recent research implicates many cofactors working in synergism with these key triggers, including the intestinal microbiota and their metabolites, nongluten dietary triggers, intestinal barrier defects, novel immune cell phenotypes, and mediators and cytokines. In addition, apart from HLA-DQ2 and -DQ8, multiple and complex predisposing genetic factors and interactions have been defined, most of which overlap with predispositions in other, usually autoimmune, diseases that are linked to CeD. The resultant better understanding of CeD pathogenesis, and its manifold manifestations has already paved the way for novel therapeutic approaches beyond the lifelong strict gluten-free diet, which poses a burden to patients and often does not lead to complete mucosal healing. Thus, supported by improved mouse models for CeD and in vitro organoid cultures, several targeted therapies are in phase 2-3 clinical studies, such as highly effective gluten-degrading oral enzymes, inhibition of TG2, cytokine therapies, induction of tolerance to gluten ingestion, along with adjunctive and preventive approaches using beneficial probiotics and micronutrients. These developments are supported by novel noninvasive markers of CeD severity and activity that may be used as companion diagnostics, allow easy-to perform and reliable monitoring of patients, and finally support personalized therapy for CeD.
Potential Make-or-Break Determinants of Celiac Disease

Ana Roque,Sónia Gonçalves Pereira

DOI: https://doi.org/10.3390/ijms25042090

IF: 5.6

2024-02-09

International Journal of Molecular Sciences

Abstract:Celiac disease is an autoimmune disease triggered by dietary gluten in genetically susceptible individuals that primarily affects the small intestinal mucosa. The sole treatment is a gluten-free diet that places a social and economic burden on patients and fails, in some, to lead to symptomatic or mucosal healing. Thus, an alternative treatment has long been sought after. Clinical studies on celiac disease have shown an association between the presence of certain microbes and disease outcomes. However, the mechanisms that underlie the effects of microbes in celiac disease remain unclear. Recent studies have employed disease models that have provided insights into disease mechanisms possibly mediated by bacteria in celiac disease. Here, we have reviewed the bacteria and related mechanisms identified so far that might protect from or incite the development of celiac disease. Evidence indicates bacteria play a role in celiac disease and it is worth continuing to explore this, particularly since few studies, to the best of our knowledge, have focused on establishing a mechanistic link between bacteria and celiac disease. Uncovering host–microbe interactions and their influence on host responses to gluten may enable the discovery of pathogenic targets and development of new therapeutic or preventive approaches.

biochemistry & molecular biology,chemistry, multidisciplinary
The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation

Dingwu Qu,Gang Wang,Leilei Yu,Fengwei Tian,Wei Chen,Qixiao Zhai

DOI: https://doi.org/10.1016/j.carbpol.2021.117651

IF: 10.723

2021-04-01

Carbohydrate Polymers

Abstract:<p>Intestinal mucins glycosylation is regulated by host cues and environmental signals from the microbiome and diets. However, the mechanisms responsible for the dialogue between these three factors and mucin glycosylation in the digestive environment of the host are not well understood. In this review, the dynamic alterations of mucin glycosylation induced by immune responses to gut diseases are summarized. The various types of interactions between mucin glycans and gut microbes, including adhesins, glycosidases, metabolic products and surface components, are discussed. The mechanisms that determine how dietary components (fat, fiber, prebiotics, protein, and food additives) affect intestinal mucin glycosylation and maintain mucosal homeostasis are identified. A potential framework for individualized dietary recommendations is proposed for the prevention of abnormal mucin glycosylation driven by immune dysregulation, gut microbiome alterations and other factors. This review may provide a basis for future research on glycosylation-inspired therapies for gut diseases.</p>

polymer science,chemistry, organic, applied
Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease

Karla A Bascuñán,Magdalena Araya,Leda Roncoroni,Luisa Doneda,Luca Elli

DOI: https://doi.org/10.1093/advances/nmz080

IF: 9.3

2019-08-09

Advances in Nutrition

Abstract:ABSTRACT The gut microbiota plays a relevant role in determining an individual's health status, and the diet is a major factor in modulating the composition and function of gut microbiota. Gluten constitutes an essential dietary component in Western societies and is the environmental trigger of celiac disease. The presence/absence of gluten in the diet can change the diversity and proportions of the microbial communities constituting the gut microbiota. There is an intimate relation between gluten metabolism and celiac disease pathophysiology and gut microbiota; their interrelation defines intestinal health and homeostasis. Environmental factors modify the intestinal microbiota and, in turn, its changes modulate the mucosal and immune responses. Current evidence from studies of young and adult patients with celiac disease increasingly supports that dysbiosis (i.e., compositional and functional alterations of the gut microbiome) is present in celiac disease, but to what extent this is a cause or consequence of the disease and whether the different intestinal diseases (celiac disease, ulcerative colitis, Crohn disease) have specific change patterns is not yet clear. The use of bacterial-origin enzymes that help completion of gluten digestion is of interest because of the potential application as coadjuvant in the current treatment of celiac disease. In this narrative review, we address the current knowledge on the complex interaction between gluten digestion and metabolism, celiac disease, and the intestinal microbiota.

nutrition & dietetics
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

L.R. Lopetuso,V. Petito,D. Zambrano,D. Orlando,A. Dal Lago,L. Serrichhio,A. Papa,A. Gasbarrini,F. Scaldaferri

DOI: https://doi.org/10.1159/000444460

2016-01-01

Digestive Diseases

Abstract:Mucosal healing (MH) represents a crucial factor for maintaining gut homeostasis. Indeed, in inflammatory bowel disease, MH has become the standard therapeutical target, because it is associated with more effective disease control, more frequent steroid-free remission, lower rates of hospitalization and surgery, and improved quality of life. In this scenario, gut microbiota is a crucial player in modulating intestinal repair and regeneration process. It can act on the tumor necrosis factor-α production, modulation of reactive oxygen and nitrogen species, activity of matrix metalloproteinases and on many other mechanisms strictly involved in restoring gut health. In this review, we analyze and review the literature on the role of gut microbiota in sustaining mucosal injury and achieving MH.

gastroenterology & hepatology
Serum anti-mullerian hormone, sex hormone, and nutrient levels in reproductive age women with celiac disease

Ailifeire Tuerxuntayi,Tian Shi,Beiyao Gao,Yan Feng,Ting Li,Wenjia Hui,Shenglong Xue,Feng Gao

DOI: https://doi.org/10.1007/s10815-024-03161-2

2024-06-23

Journal of Assisted Reproduction and Genetics

Abstract:This study aimed to investigate the changes in serum Anti-Müllerian Hormone (AMH) levels, sex hormone levels, follicle-stimulating hormone (FSH)/luteinizing hormone (LH) ratio in patients with celiac disease (CeD), and their correlation with clinical characteristics and nutrient levels.

genetics & heredity,obstetrics & gynecology,reproductive biology
Coeliac Disease and Mast Cells

Barbara Frossi,Marco De Carli,Antonino Calabrò

DOI: https://doi.org/10.3390/ijms20143400

2019-07-11

Abstract:Over the last decades, there has been an impressive progress in our understanding of coeliac disease pathogenesis and it has become clear that the disorder is the final result of complex interactions of environmental, genetic, and immunological factors. Coeliac disease is now considered a prototype of T-cell-mediated disease characterized by loss of tolerance to dietary gluten and the targeted killing of enterocytes by T-cell receptor αβ intraepithelial lymphocytes. Accumulating evidence, however, indicates that the induction of a gluten-specific T helper-1 response must be preceded by the activation of the innate immune system. Mast cells are key players of the innate immune response and contribute to the pathogenesis of a multitude of diseases. Here, we review the results of studies aimed at investigating the role of mast cells in the pathogenesis of coeliac disease, showing that these cells increase in number during the progression of the disease and contribute to define a pro-inflammatory microenvironment.
Editorial: Mucosal healing with steroids: Once upon a time in ulcerative colitis

Manuel Barreiro‐de Acosta,Iago Rodríguez‐Lago

DOI: https://doi.org/10.1111/apt.18094

IF: 9.524

2024-06-09

Alimentary Pharmacology & Therapeutics

Abstract:LINKED CONTENT This article is linked to Fukuda et al papers. To view these articles, visit https://doi.org/10.1111/apt.18013 and https://doi.org/10.1111/apt.18111

pharmacology & pharmacy,gastroenterology & hepatology
Editorial: Mucosal healing with steroids—Once upon a time in ulcerative colitis. Authors' reply

Tomohiro Fukuda,Hajime Yamazaki,Katsuyoshi Matsuoka

DOI: https://doi.org/10.1111/apt.18111

IF: 9.524

2024-06-09

Alimentary Pharmacology & Therapeutics

Abstract:LINKED CONTENT This article is linked to Fukuda et al papers. To view these articles, visit https://doi.org/10.1111/apt.18013 and https://doi.org/10.1111/apt.18094

pharmacology & pharmacy,gastroenterology & hepatology
Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics

Katherine L Olshan,Maureen M Leonard,Gloria Serena,Ali R Zomorrodi,Alessio Fasano

DOI: https://doi.org/10.1080/1744666X.2021.1840354

2021-01-01

Expert Review of Clinical Immunology

Abstract:Current evidence supports a vital role of the microbiota on health outcomes, with alterations in an otherwise healthy balance linked to chronic medical conditions like celiac disease (CD). Recent advances in microbiome analysis allow for unparalleled profiling of the microbes and metabolites. With the growing volume of data available, trends are emerging that support a role for the gut microbiota in CD pathogenesis. In this article, the authors review the relationship between factors such as genes and antibiotic exposure on CD onset and the intestinal microbiota. The authors also review other microbiota within the human body (like the oropharynx) that may play a role in CD pathogenesis. Finally, the authors discuss implications for disease modification and the ultimate goal of prevention. The authors reviewed literature from PubMed, EMBASE, and Web of Science. CD serves as a unique opportunity to explore the role of the intestinal microbiota on the development of chronic autoimmune disease. While research to date provides a solid foundation, most studies have been case-control and thus do not have capacity to explore the mechanistic role of the microbiota in CD onset. Further longitudinal studies and integrated multi-omics are necessary for investigating CD pathogenesis.

immunology
Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice

Esther Colomier,Joost P Algera,Karen Van den Houte,Magnus Simrén,Jan Tack

DOI: https://doi.org/10.1016/j.bpg.2023.101824

Abstract:A subgroup of patients with a disorder of gut-brain interaction (DGBI) report symptoms such as abdominal pain, gas-related symptoms, dyspeptic symptoms and loose stool or urgency after meal intake. Therefore, the effect of several dietary therapies including fibre-rich or restrictive diets have already been studied in patients with irritable bowel syndrome, functional abdominal bloating or distention, and functional dyspepsia. However, there is a paucity of studies in the literature on the mechanisms underlying food-related symptoms. Therefore, this review focuses on these potential mechanisms and explains the role of nutrient sensing and tasting, physical considerations, malabsorption or allergy-like reaction to food and its interaction with microbiota. In addition, it emphasizes the importance of future research and clinical practice regarding food-related symptoms in patients with a DGBI.
Factors Associated with Mucosal Healing in Patients with Ulcerative Colitis in Clinical Remission.

Hai Yun Shi,Francis K L Chan,Steven W C Tsang,Yee Tak Hui,Shun Fung Sze,Jessica Y L Ching,Tiffany Chung,Y,Fu Hang Lo,Edwin H S Shan,K,Justin C Y Wu,Joseph J Y Sung,Siew C Ng

DOI: https://doi.org/10.1097/mib.0000000000000334

2015-01-01

Inflammatory Bowel Diseases

Abstract:BACKGROUND:Mucosal healing (MH) has been associated with improved outcomes in ulcerative colitis but factors associated with MH are not well defined. METHODS:Consecutive patients with ulcerative colitis in clinical remission (Mayo symptomatic subscore = 0) who had at least 1 colonoscopy since diagnosis from 6 centers were included. For patients who had at least 2 colonoscopies during follow-up, each colonoscopy was reviewed to define whether they had early MH (Mayo endoscopic subscore reduced to 0 within 3 yr of clinical remission). Factors associated with MH and early MH were determined using logistic regression. RESULTS:Two hundred thirty-seven patients with ulcerative colitis (mean age 50.39 ± 14.10 yr; 56.5% male) were included. Independent factors for MH were clinical remission >3 years (odds ratio [OR] 4.0; 95% confidence interval [CI], 1.2-13.1), mild/moderate mucosal inflammation (OR 3.3; 95% CI, 1.3-8.5), and immunosuppressant use (OR 4.6; 95% CI, 1.5-14.6). Among patients who had ≥2 of above factors, 74% achieved MH, whereas only 39% with <2 factors achieved MH (P < 0.001). Of patients in clinical remission <1 year, 1 to 3 years and >3 years, 30%, 45.9%, and 62.9% achieved MH, respectively. Immunosuppressant therapy was associated with early MH (P = 0.025). In multivariate analysis, patients with previous mild inflammation were more likely to achieve early MH than those with moderate/severe inflammation (OR 2.8; 95% CI, 1.2-6.2). CONCLUSIONS:A longer disease remission, previous less severe mucosal inflammation, and immunosuppressant use are associated with MH. Severity of mucosal inflammation and use of immunosuppressant are also associated with early MH.
Assessing mucosal recovery in celiac disease � Time to diagnosis and histological severity as determining factors

Laura Rodríguez Martín,Luis Manuel Vaquero Ayala,Mercedes Hernando Martín,Santiago Vivas Alegre

DOI: https://doi.org/10.17235/reed.2024.9968/2023

2024-01-01

Revista Española de Enfermedades Digestivas

Abstract:Study background and objectives: There is great disparity in mucosal recovery among celiac patients on a gluten-free diet. We report a study to identify associated factors.METHODS: Celiac patient cases were collected that had positive celiac serology and villous atrophy at diagnosis, and had undergone a control biopsy after at least 12 months of follow-up.RESULTS: We included 70 celiac patients. They had experienced symptoms for 9.05 ± 9.48 years before being diagnosed. After follow-up for 2.93 ± 1.94 years, 34.3 % had complete mucosal recovery and 57.1 % had partial mucosal recovery. In the comparative analysis we found no relationship between mucosal recovery and sex, age, clinical manifestations or follow-up time from diagnosis to second biopsy. Time with clinical manifestations before diagnosis was associated with a worse outcome: 2.64 years in patients with full recovery, 4.61 years in patients with partial recovery, and 14.26 years in patients with persistent villous atrophy. Higher transglutaminase antibody titers both at diagnosis and during follow-up were associated with poorer histologic outcomes. We observed higher mucosal recovey rates in patients with mild atrophy versus severe atrophy at diagnosis.CONCLUSIONS: In spite of gluten-free diet a significant proportion of patients have persistent histologic changes. Time with clinical manifestations before diagnosis is key for histological severity and recovery.

gastroenterology & hepatology

Letter: the Relationship Between Diet, Mood and Mucosal Healing in Coeliac Disease Remains to Be Verified

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy

Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications

Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review

Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment

Review article: Mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn's disease

Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment

Potential Make-or-Break Determinants of Celiac Disease

The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation

Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Serum anti-mullerian hormone, sex hormone, and nutrient levels in reproductive age women with celiac disease

Coeliac Disease and Mast Cells

Editorial: Mucosal healing with steroids: Once upon a time in ulcerative colitis

Editorial: Mucosal healing with steroids—Once upon a time in ulcerative colitis. Authors' reply

Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics

Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice

Factors Associated with Mucosal Healing in Patients with Ulcerative Colitis in Clinical Remission.

Assessing mucosal recovery in celiac disease � Time to diagnosis and histological severity as determining factors